exosome-based GBM therapeutic
/ Exousia Pro
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
October 28, 2025
Exousia Pro, Inc…is pleased to announce it has received Orphan Drug Designation from the FDA, for malignant Glioma, aka Glioblastoma multiforme (GBM).
(ACCESS Newswire)
Orphan drug • Glioblastoma
1 to 1
Of
1
Go to page
1